Short answer
Core Laboratories Inc. /DE/ (CLB) filed an 8-K current report with the SEC on July 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results announced on July 29, 2026.
Core Laboratories Inc. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results announced on July 29, 2026
- Earnings details and operating performance contained in the accompanying press release exhibit
Item 7.01 · Regulation FD Disclosure
- Quarterly cash dividend of $0.01 per share announced
- August 10, 2026 record date; August 31, 2026 payment date
- Dividend provides direct shareholder return and signals continued cash-distribution capacity
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $124.6M, down 4% YoY, while operating income $9.2M and EPS $0.13 reflected sequential recovery
- Production Enhancement drove momentum, with revenue up 15% sequentially to $45.9M and operating income up 550% sequentially to $5.2M
- Reservoir Description remained pressured, with revenue down 9% YoY to $78.7M amid Middle East and Russia-Ukraine disruptions
- Free cash flow $3.1M, net debt $93.6M, and leverage 1.30x supported continued capital returns
- Q3 revenue guidance $128.5M–$135.5M and EPS $0.12–$0.20, alongside a $0.01 quarterly dividend and $2.7M share repurchase
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Core Laboratories Inc. /DE/ 8-K filings
Get the next CLB 8-K as it lands
Follow CLB for push alerts, or ask the research agent what this filing means.